184 related articles for article (PubMed ID: 26330184)
1. Faecal proteomics: A tool to investigate dysbiosis and inflammation in patients with cystic fibrosis.
Debyser G; Mesuere B; Clement L; Van de Weygaert J; Van Hecke P; Duytschaever G; Aerts M; Dawyndt P; De Boeck K; Vandamme P; Devreese B
J Cyst Fibros; 2016 Mar; 15(2):242-50. PubMed ID: 26330184
[TBL] [Abstract][Full Text] [Related]
2. Dysbiosis of bifidobacteria and Clostridium cluster XIVa in the cystic fibrosis fecal microbiota.
Duytschaever G; Huys G; Bekaert M; Boulanger L; De Boeck K; Vandamme P
J Cyst Fibros; 2013 May; 12(3):206-15. PubMed ID: 23151540
[TBL] [Abstract][Full Text] [Related]
3. A Method for Comprehensive Proteomic Analysis of Human Faecal Samples to Investigate Gut Dysbiosis in Patients with Cystic Fibrosis.
Debyser G; Aerts M; Van Hecke P; Mesuere B; Duytschaever G; Dawyndt P; De Boeck K; Vandamme P; Devreese B
Adv Exp Med Biol; 2019; 1073():137-160. PubMed ID: 31236842
[TBL] [Abstract][Full Text] [Related]
4. Gut Microbiota in Children With Cystic Fibrosis: A Taxonomic and Functional Dysbiosis.
Coffey MJ; Nielsen S; Wemheuer B; Kaakoush NO; Garg M; Needham B; Pickford R; Jaffe A; Thomas T; Ooi CY
Sci Rep; 2019 Dec; 9(1):18593. PubMed ID: 31819107
[TBL] [Abstract][Full Text] [Related]
5. Gut microbiota signatures in cystic fibrosis: Loss of host CFTR function drives the microbiota enterophenotype.
Vernocchi P; Del Chierico F; Russo A; Majo F; Rossitto M; Valerio M; Casadei L; La Storia A; De Filippis F; Rizzo C; Manetti C; Paci P; Ercolini D; Marini F; Fiscarelli EV; Dallapiccola B; Lucidi V; Miccheli A; Putignani L
PLoS One; 2018; 13(12):e0208171. PubMed ID: 30521551
[TBL] [Abstract][Full Text] [Related]
6. Development of the gut microbiota in early life: The impact of cystic fibrosis and antibiotic treatment.
Kristensen M; Prevaes SMPJ; Kalkman G; Tramper-Stranders GA; Hasrat R; de Winter-de Groot KM; Janssens HM; Tiddens HA; van Westreenen M; Sanders EAM; Arets B; Keijser B; van der Ent CK; Bogaert D
J Cyst Fibros; 2020 Jul; 19(4):553-561. PubMed ID: 32487494
[TBL] [Abstract][Full Text] [Related]
7. Fecal dysbiosis and inflammation in intestinal-specific Cftr knockout mice on regimens preventing intestinal obstruction.
Young SM; Woode RA; Williams EC; Ericsson AC; Clarke LL
Physiol Genomics; 2024 Mar; 56(3):247-264. PubMed ID: 38073491
[TBL] [Abstract][Full Text] [Related]
8. Associations between micronutrient intakes and gut microbiota in a group of adults with cystic fibrosis.
Li L; Krause L; Somerset S
Clin Nutr; 2017 Aug; 36(4):1097-1104. PubMed ID: 27595636
[TBL] [Abstract][Full Text] [Related]
9. The Enigmatic Gut in Cystic Fibrosis: Linking Inflammation, Dysbiosis, and the Increased Risk of Malignancy.
Garg M; Ooi CY
Curr Gastroenterol Rep; 2017 Feb; 19(2):6. PubMed ID: 28155088
[TBL] [Abstract][Full Text] [Related]
10. Metagenomic evidence for taxonomic dysbiosis and functional imbalance in the gastrointestinal tracts of children with cystic fibrosis.
Manor O; Levy R; Pope CE; Hayden HS; Brittnacher MJ; Carr R; Radey MC; Hager KR; Heltshe SL; Ramsey BW; Miller SI; Hoffman LR; Borenstein E
Sci Rep; 2016 Mar; 6():22493. PubMed ID: 26940651
[TBL] [Abstract][Full Text] [Related]
11. Statistical Evaluation of Metaproteomics and 16S rRNA Amplicon Sequencing Techniques for Study of Gut Microbiota Establishment in Infants with Cystic Fibrosis.
Saralegui C; García-Durán C; Romeu E; Hernáez-Sánchez ML; Maruri A; Bastón-Paz N; Lamas A; Vicente S; Pérez-Ruiz E; Delgado I; Luna-Paredes C; Caballero JD; Zamora J; Monteoliva L; Gil C; Del Campo R
Microbiol Spectr; 2022 Dec; 10(6):e0146622. PubMed ID: 36255300
[TBL] [Abstract][Full Text] [Related]
12. Intestinal function and transit associate with gut microbiota dysbiosis in cystic fibrosis.
Marsh R; Gavillet H; Hanson L; Ng C; Mitchell-Whyte M; Major G; Smyth AR; Rivett D; van der Gast C
J Cyst Fibros; 2022 May; 21(3):506-513. PubMed ID: 34895838
[TBL] [Abstract][Full Text] [Related]
13. Intestinal Metaproteomics Reveals Host-Microbiota Interactions in Subjects at Risk for Type 1 Diabetes.
Gavin PG; Mullaney JA; Loo D; Cao KL; Gottlieb PA; Hill MM; Zipris D; Hamilton-Williams EE
Diabetes Care; 2018 Oct; 41(10):2178-2186. PubMed ID: 30100563
[TBL] [Abstract][Full Text] [Related]
14. An
Barrack KE; Hampton TH; Valls RA; Surve SV; Gardner TB; Sanville JL; Madan JL; O'Toole GA
J Bacteriol; 2024 Jan; 206(1):e0028623. PubMed ID: 38169295
[TBL] [Abstract][Full Text] [Related]
15. Development of an Index Score for Intestinal Inflammation-Associated Dysbiosis Using Real-World Stool Test Results.
Chen L; Reynolds C; David R; Peace Brewer A
Dig Dis Sci; 2020 Apr; 65(4):1111-1124. PubMed ID: 31529411
[TBL] [Abstract][Full Text] [Related]
16. A decrease of the butyrate-producing species Roseburia hominis and Faecalibacterium prausnitzii defines dysbiosis in patients with ulcerative colitis.
Machiels K; Joossens M; Sabino J; De Preter V; Arijs I; Eeckhaut V; Ballet V; Claes K; Van Immerseel F; Verbeke K; Ferrante M; Verhaegen J; Rutgeerts P; Vermeire S
Gut; 2014 Aug; 63(8):1275-83. PubMed ID: 24021287
[TBL] [Abstract][Full Text] [Related]
17. Relationship between airway dysbiosis, inflammation and lung function in adults with cystic fibrosis.
Frey DL; Boutin S; Dittrich SA; Graeber SY; Stahl M; Wege S; Herth FJF; Sommerburg O; Schultz C; Mall MA; Dalpke AH
J Cyst Fibros; 2021 Sep; 20(5):754-760. PubMed ID: 33431308
[TBL] [Abstract][Full Text] [Related]
18. Bacterial overgrowth, dysbiosis, inflammation, and dysmotility in the Cystic Fibrosis intestine.
Dorsey J; Gonska T
J Cyst Fibros; 2017 Nov; 16 Suppl 2():S14-S23. PubMed ID: 28986022
[TBL] [Abstract][Full Text] [Related]
19. Reduced Abundance of Butyrate-Producing Bacteria Species in the Fecal Microbial Community in Crohn's Disease.
Takahashi K; Nishida A; Fujimoto T; Fujii M; Shioya M; Imaeda H; Inatomi O; Bamba S; Sugimoto M; Andoh A
Digestion; 2016; 93(1):59-65. PubMed ID: 26789999
[TBL] [Abstract][Full Text] [Related]
20. Fecal dysbiosis in infants with cystic fibrosis is associated with early linear growth failure.
Hayden HS; Eng A; Pope CE; Brittnacher MJ; Vo AT; Weiss EJ; Hager KR; Martin BD; Leung DH; Heltshe SL; Borenstein E; Miller SI; Hoffman LR
Nat Med; 2020 Feb; 26(2):215-221. PubMed ID: 31959989
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
